Pegylated (40 kDa) interferon alfa-2A (PEGASYS®) in new combination therapies:: A report of a randomized, multicenter efficacy and safety study

被引：6

作者：

Di Bisceglie, AM

Bernstein, DE

Rustgi, VR

Gitlin, N

Jeffers, LJ

Simon, D

Campagna, J

Pappas, SC

机构：

[1] St Louis Univ, Bethesda Hosp, St Louis, MO 63103 USA

[2] N Shore Univ Hosp, Manhasset, NY 11030 USA

[3] Georgetown Univ, Fairfax, VA USA

[4] Atlanta Gastroenterol Associates, Atlanta, GA USA

[5] Univ Miami, Sch Med, Miami, FL USA

[6] A Jacobi Med Ctr, Bronx, NY USA

[7] Roche Labs Inc, Nutley, NJ USA

来源：

关键词：

D O I：

10.1016/S0168-8278(01)81398-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：143 / 143

页数：1